LLT-1与NLRC4炎症小体的相关性及其对胶质母细胞瘤预后的影响
研究在胶质母细胞瘤组织中检测NLRC4炎症小体组分与LLT-1表达,结合RNA测序和免疫荧光分析其关联。LLT-1主要与表达GFAP的星形胶质细胞共定位,并与活化NLRC4炎症小体共表达;LLT-1高表达与不良预后相关,尤其在间质亚型。
要点
- LLT-1在胶质母细胞瘤中主要与GFAP阳性星形胶质细胞共定位,不与Iba-1小胶质细胞标志物共定位。
- LLT-1与活化NLRC4炎症小体在瘤内星形胶质细胞中共表达,提示二者关联。
- LLT-1高表达与不良预后相关,尤其在间质亚型,并富集TNF和NOD样受体信号通路。
核心结论
- 研究揭示NLRC4炎症小体活性与LLT-1表达存在关联,提示涉及TNF、炎症小体和IL-1的新型调控通路,可能为NK细胞介导的抗胶质瘤方法提供新思路。
研究设计与样本
- 收集胶质母细胞瘤组织进行RNA测序和免疫荧光实验,并通过免疫荧光评估LLT-1与其他蛋白的共定位。
- 计算分析分别使用中国胶质瘤基因组图谱296例患者和CHA医疗记录52例患者的RNA测序数据,进行生存分析、非负矩阵分解聚类、基因本体富集和蛋白-蛋白相互作用分析。
- 通过单细胞RNA测序分析确认肿瘤与免疫细胞间的受体-配体相互作用。
主要发现
- 在胶质母细胞瘤组织中,LLT-1主要与表达胶质纤维酸性蛋白(GFAP)的星形胶质细胞共定位,而不与小胶质细胞标志物Iba-1共定位。
- LLT-1与活化NLRC4炎症小体主要在瘤内星形胶质细胞中共表达,提示LLT-1、NLRC4与胶质瘤恶性程度之间存在关联。
- LLT-1高表达与不良预后相关,尤其在间质亚型中,并与TNF和NOD样受体信号通路富集相关,提示在肿瘤炎症和进展中可能发挥作用。
- 在单细胞水平,间质样恶性细胞与其他恶性细胞类型相比,显示高NF、NLR和IL-1信号通路富集。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: LLT-1 is a well-known ligand for the natural killer (NK) cell inhibitory receptor NKRP1A. Here, we examined NLRC4 inflammasome components and LLT-1 expression in glioblastoma (GBM) tissues to elucidate potential associations and interactions between these factors. METHODS: GBM tissues were collected for RNA sequencing (RNA-seq) and Immunofluorescent experiments. Colocalization of LLT-1 and other proteins was assessed by immunofluorescence. Computational analyses utilized RNA-seq data from 296 to 52 patients from the Chinese Glioma Genome Atlas and CHA medical records, respectively. These data were subjected to survival, non-negative matrix factorization clustering, Gene Ontology enrichment, and protein-protein interaction analyses. Receptor-ligand interactions between tumor and immune cells were confirmed by single-cell RNA-seq analysis. RESULTS: In GBM tissues, LLT-1 was predominantly colocalized with glial fibrillary acidic protein (GFAP)-expressing astrocytes, but not with microglial markers like Iba-1. Additionally, LLT-1 and activated NLRC4 inflammasomes were mainly co-expressed in intratumoral astrocytes, suggesting an association between LLT-1, NLRC4, and glioma malignancy. High LLT-1 expression correlates with poor prognosis, particularly in the mesenchymal subtype, and is associated with TNF and NOD-like receptor signaling pathway enrichment, indicating a potential role in tumor inflammation and progression. At the single-cell level, mesenchymal-like malignant cells showed high NF, NLR, and IL-1 signaling pathway enrichment compared to other malignant cell types. CONCLUSION: We revealed an association between NLRC4 inflammasome activity and LLT-1 expression, suggesting a novel regulatory pathway involving TNF, inflammasomes, and IL-1, potentially offering new NK-cell-mediated anti-glioma approaches.
引用
- Park J, Kim YJ, Lee M, et al. Correlation of LLT-1 and NLRC4 inflammasome and its effect on glioblastoma prognosis. J Neurooncol. 2024. PMID: 38907949. doi:10.1007/s11060-024-04750-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。